{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:50:54Z","timestamp":1785196254272,"version":"3.55.0"},"reference-count":14,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,9,5]],"date-time":"2006-09-05T00:00:00Z","timestamp":1157414400000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:p><jats:bold><jats:sc>Abstract:\u2002<\/jats:sc><\/jats:bold>  <jats:bold>The aim of this study was to evaluate the potential diagnostic value of quantitative analysis of human telomerase reverse transcriptase (hTERT) mRNA in plasma for noninvasive diagnosis of prostate cancer (PCa). Expression levels of hTERT were analyzed by real\u2010time quantitative RT\u2010PCR in 68 patients showing elevated prostate\u2010specific antigen (PSA) levels and a control group of 44 healthy volunteers. Sensitivity and specificity were determined and compared to the corresponding PSA values. Median values for hTERT gene expression in the PCa patients (0.72 ng; range 0.01\u201312.86) were statistically significantly higher (<jats:italic>P<\/jats:italic> &lt; 0.001) than in the control group (0.13 ng; 0.02\u20130.35). Patients with clinically confirmed prostatitis showed lower plasma hTERT expression than PCa patients (0.29; 0.01\u201366.07). At a cutoff value of 0.35 sensitivity and specificity for the diagnosis of PCa were 81% and 60%, respectively. We suggest that hTERT mRNA in plasma is a very specific and sensitive method that may aid to differentiate between malignant and nonmalignant prostate tissue and may be a useful marker (in combination with PSA) for early PCa diagnosis.<\/jats:bold> <\/jats:p>","DOI":"10.1196\/annals.1368.028","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T03:12:04Z","timestamp":1163646724000},"page":"204-210","source":"Crossref","is-referenced-by-count":34,"title":["Real\u2010Time Quantification of Human Telomerase Reverse Transcriptase mRNA in the Plasma of Patients with Prostate Cancer"],"prefix":"10.1111","volume":"1075","author":[{"given":"F.","family":"DAS\u00cd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"MART\u00cdNEZ\u2010RODES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"MARCH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"SANTAMAR\u00cdA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"MART\u00cdNEZ\u2010JAVALOYAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"GIL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.F.","family":"ALI\u00d1O","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,9,5]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.53.1.5"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1919"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0022-5347(17)32412-6","article-title":"Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening of the National Cancer Institute","volume":"152","author":"Gohagen J.K.","year":"1994","journal-title":"J. Urol."},{"key":"e_1_2_5_5_2","first-page":"1273","article-title":"Prostate\u2010specific antigen: what\u00b4s new in 1997","volume":"11","author":"Pannek J.","year":"1997","journal-title":"Oncology"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1078-1439(00)00094-6"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0200"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1487"},{"key":"e_1_2_5_9_2","first-page":"245","article-title":"Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer","volume":"11","author":"Novakovic S.","year":"2004","journal-title":"Oncol. Rep."},{"key":"e_1_2_5_10_2","first-page":"1961","article-title":"Detection of tumor messenger RNA in the serum of patients with malignant melanoma","volume":"5","author":"Kopreski M.S.","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_5_11_2","first-page":"3823","article-title":"Telomerase RNA as detection marker in the serum of breast cancer patients","volume":"6","author":"Chen X.","year":"2000","journal-title":"Clin. Cancer. Res."},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780285"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2004.00627.x"},{"key":"e_1_2_5_14_2","first-page":"2695","article-title":"DD3PCA3, a very sensitive and specific marker to detect prostate tumors","volume":"62","author":"De Kok J.B.","year":"2002","journal-title":"Cancer Res."},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199104253241702"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1196%2Fannals.1368.028","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1196\/annals.1368.028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T04:01:31Z","timestamp":1695614491000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1196\/annals.1368.028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1196\/annals.1368.028"],"URL":"https:\/\/doi.org\/10.1196\/annals.1368.028","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}